Renapta Overview

  • Founded
  • 2010


  • Status
  • Private

  • Latest Deal Type
  • 2ndary - Private

  • Investors
  • 1

Renapta General Information


Developer of a medical system designed to be used for the treatment of kidney impairment. The company's product is used for the selective clearance of certain uremic toxins from the blood of end-stage renal disease patients undergoing renal dialysis, enabling patients to access kidney impairment treatment.

Contact Information

Ownership Status
Privately Held (backing)
Financing Status
Formerly VC-backed
Primary Industry
Other Devices and Supplies
Primary Office
  • Van Siburgstraat 34
  • 3863 HW Nijkerk
  • Netherlands

Want detailed data on 3M+ companies?

What you see here scratches the surface

Request a free trial

Want to dig into this profile?

We’ll help you find what you need

Learn more

Renapta Valuation & Funding

Deal Type Date Amount Raised to Date Post-Val Status Stage
3. Secondary Transaction - Private 01-May-2021 Completed Generating Revenue
2. Grant 01-Jun-2017 Completed Startup
1. Early Stage VC 01-Jan-2010 Completed Startup
To view Renapta’s complete valuation and funding history, request access »

Renapta Patents

Renapta Recent Patent Activity

Publication ID Patent Title Status First Filing Date Technology (CPC) Citations
CA-2897372-A1 Artificial kidney Active 14-Jun-2007 0000000000
CA-2690785-A1 Artificial kidney Active 14-Jun-2007 0000000000
CA-2690785-C Artificial kidney Active 14-Jun-2007 0000000000
CA-2897372-C Artificial kidney Active 14-Jun-2007 0000000000
EP-2402047-A1 Device for detoxification and use of such a device Active 14-Jun-2007 A61M1/3472 0
To view Renapta’s complete patent history, request access »

Renapta Executive Team (3)

Name Title Board Seat Contact Info
Francis Houwen Co-Founder
Jacobus Musters Co-Founder
You’re viewing 2 of 3 executive team members. Get the full list »

Renapta Investors (1)

Investor Name Investor Type Holding Investor Since Participating Rounds Contact Info
Dutch Ministry of Economic affairs Government 000 0000 000000 0
To view Renapta’s complete investors history, request access »